CI 898 trihydrochloride
Unfortunately CI 898 trihydrochloride (Cat. No. 2039) was withdrawn from sale in Sep. 2016 for commercial reasons.
To view previous batch information for CI 898 trihydrochloride (Cat. No. 2039) please follow the links below:
Certificate of Analysis / Safety Data Sheet
Keywords: Dihydrofolate reductases inhibitors inhibits Antineoplastic agent affects G1/S phase progression DHFR Cell Cycle CI898 trihydrochloride
Find multiple products by catalog number
New Products in this Area
Irreversible TxrR inhibitorPemetrexed
High affinity dihydrofolate reductase inhibitor; also inhibits thymidylate synthase, GARFT and AICARTD9
Potent thioredoxin reductase (TxrR) inhibitorMK 386
Potent, selective human type 1 5α-reductase inhibitorCCF 642
Protein disulfide isomerase (PDI) inhibitor
Follow @Tocris on Twitter
Tocris is now actively tweeting. For regular updates on news, events and special offers, follow @Tocris on Twitter.